$29.34
0.000.00%
Pre-Market: Dec 20, 4:05 PM EDT
Comments
Loading...
Akero Therapeutics (NASDAQ:AKRO) Stock, Earnings Estimates, EPS, And Revenue
Akero Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 27
EPS Estimate
$-1.130
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Akero Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Akero Therapeutics (AKRO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-08 | $-1.05 | $-0.90 | -16.7 % |
| Jun 2024 | 2024-08-09 | $-0.81 | $-0.90 | 10.0 % |
| Mar 2024 | 2024-05-10 | $-0.90 | $-0.95 | 5.26 % |
| Dec 2023 | 2024-02-29 | $-0.99 | $-0.86 | -15.1 % |
Akero Therapeutics (AKRO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Akero Therapeutics (NASDAQ:AKRO) reporting earnings?
Akero Therapeutics (AKRO) is scheduled to report earnings on February 27, 2025. The last reported earnings were for reported on November 8, 2024 for Q3.
What were the latest earnings per share (EPS) for Akero Therapeutics (NASDAQ:AKRO)?
The Actual EPS was $-1.05, which missed the estimate of $-0.90.
What were Akero Therapeutics’s (NASDAQ:AKRO) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.